SOT106 (Antibody-drug conjugate, targeting LRRC15)

Indicaton

solid tumors, sarcomas

Therapeutic indications

Oncology

Type of product

Table

Phase

Discovery
Partnering status

Not partnered

You may also be interested in

SOT201 (Immunocytokine, PD-1 x IL-15)

solid tumors

Phase I started

SOT109 (Antibody-Drug Conjugate)

solid tumors, mainly colorectal

Discovery

AUP-55

AUP-55 is a Cell & Gene Therapy for local injection, for the treatment of ovarian cancer, peritoneal carcinomatosis, bladder cancer. AUP-55 consists of genetically engineered lactic acid bacteria including endogenous TLR2, TLR9, NOD2 agonists and producing human-interferon-alpha 2B and Interleukin-15-Sushi super agonist

Discovery